NEW YORK (GenomeWeb) – Exact Sciences said on Wednesday that a Medicare panel has unanimously voted to keep the reimbursement rate for the firm's Cologuard test at $492.72.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
The Economist writes that an increasing number of scientific journals don't do peer review.
In Science this week: genetic overlap among many psychiatric disorders, and more.
This webinar will present data from the FLAURA trial and show the clinical utility of liquid biopsy in identifying non-small-cell lung cancer (NSCLC) patients who may benefit from targeted TKI therapies.
This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.